A detailed history of First National Advisers, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, First National Advisers, LLC holds 4,341 shares of UTHR stock, worth $1.58 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
4,341
Previous 4,008 8.31%
Holding current value
$1.58 Million
Previous $1.28 Million 21.87%
% of portfolio
0.25%
Previous 0.24%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$311.04 - $363.55 $103,576 - $121,062
333 Added 8.31%
4,341 $1.56 Million
Q2 2024

Aug 13, 2024

BUY
$228.26 - $319.04 $914,866 - $1.28 Million
4,008 New
4,008 $1.28 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track First National Advisers, LLC Portfolio

Follow First National Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First National Advisers, LLC with notifications on news.